Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Permanyer
2022-07-01
|
| Schriftenreihe: | Gaceta Mexicana de Oncología |
| Schlagworte: | |
| Online-Zugang: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|